U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501819) titled 'Sympathetic Ablation for Ventricular Arrhythmias' on March 24.
Brief Summary: Enrolled patients will undergo an acute procedure in which a catheter is inserted near the heart to ablate a sympathetic nerve, reducing signals that trigger ventricular arrhythmias.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Ventricular Tachycardia (VT)
Intervention:
DEVICE: Central sympathetic nerve ablation
Catheter-based ablation of an extra-cardiac nerve target
Recruitment Status: NOT_YET_RECRUITING
Sponsor: SymKardia
Published by HT Digital Content Services with permission from Health Daily Digest....